← Eichor
Condition: Symptomatic Aortic Stenosis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Symptomatic Aortic Stenosis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Treatment Effects of Bisoprolol and Verapamil in Symptomatic Patients With Non-obstructive Hypertrophic Cardiomyopathy
Phase 4 · 4 location(s) · Morten Steen Kvistholm Jensen · NCT05569382
PERFECT - Portuguese Evolut Registry Studying the Outcomes of Medtronic Evolut™ FX+ TAVI System by Evaluating an Optimal
Phase N/A · 12 location(s) · Portuguese Association of Interventional Cardiology · NCT07343674
A Study to Assess the Safety of Mavacamten in Korean Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Phase N/A · 2 location(s) · Bristol-Myers Squibb · NCT06146660
Structured Shared Decision Making for Patients Undergoing SAVR or TAVR
NA · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT05711186
LANDMARK Trial: a Randomised Controlled Trial of Myval THV
NA · 54 location(s) · Meril Life Sciences Pvt. Ltd. · NCT04275726
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes
Phase N/A · 99 location(s) · Bristol-Myers Squibb · NCT05489705
FIH Study of the GEMINUS TAVI System in Patients With Severe Symptomatic Aortic Stenosis
NA · 2 location(s) · Valve Medical · NCT05909748
Surgical vs Transcatheter Aortic Valve Replacement in YOUNG Patients
NA · 49 location(s) · Ceric Sàrl · NCT06861361
Transcatheter Aortic Valve Replacement Single Center Registry in Chinese Population
Phase 4 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT02803294
A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic
Phase 3 · 108 location(s) · Lexicon Pharmaceuticals · NCT06481891
Myocardial Perfusion Changes Following Optimal Medical Treatment in Symptomatic Hypertrophic Cardiomyopathy
Phase N/A · 1 location(s) · Medical University of Vienna · NCT07150299
Colibri Transcatheter Aortic Heart Valve System Study
NA · 5 location(s) · Colibri Heart Valve LLC · NCT04029844
Isolated Surgical Aortic Valve Replacement in Low Risk AS Patients
NA · 37 location(s) · Osaka University · NCT06924151
STS/ACC Transcatheter Valve Therapy Registry (TVT Registry)
Phase N/A · 1 location(s) · The Society of Thoracic Surgeons · NCT01737528
Complete Functional Assessment of Intermediate Coronary Artery Stenosis Before and After Transcatheter Aortic Valve Impl
NA · 1 location(s) · Helios Health Institute GmbH · NCT05133843
Pivotal Study of the Vienna Transcatheter Self Expandable Aortic Valve SE System
NA · 31 location(s) · P+F Products + Features GmbH · NCT04861805
A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic C
Phase 2 · 67 location(s) · Imbria Pharmaceuticals, Inc. · NCT07023614
STAR Trial (Siegel Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis)
NA · 1 location(s) · MiRus · NCT07278310
Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MY
Phase 1/Phase 2 · 10 location(s) · Tenaya Therapeutics · NCT05836259
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing
NA · 72 location(s) · University of British Columbia · NCT04634240
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.